Ganetespib-impurities | Pharmaffiliates

ganetespib

Ganetespib potentiates the anti-cancer effects of lapatinib in ErbB2+ breast cancer cells. Ganetespib is under investigation for the treatment of Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome. Reference standards of Ganetespib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ganetespib
    [catalogue_number] => PA 07 49000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 364.30
    [form] => C20H20N4O3
    [cas] => 888216-25-9
    [pslug] => 888216-25-9-ganetespib-api-pa0749000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 07 49000

Ganetespib


  • Catalogue No.:PA 07 49000

  • CAS :

    888216-25-9

  • Molecular Formula : C20H20N4O3

  • Molecular Weight : 364.30